|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| A61P 11/00 | |||
| C07K 16/22 | |||
| A61K 45/06 |
| (11) | Patento numeris | 2083863 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07867199.7 |
| Europos patento paraiškos padavimo data | 2007-10-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-08-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-03-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2007/021234 |
| Data | 2007-10-03 |
| (87) | Numeris | WO 2008/060371 |
| Data | 2008-05-22 |
| (30) | Numeris | Data | Šalis |
| 827933 P | 2006-10-03 | US |
| (72) |
STREISAND, James B., US
ROBERTS, Jesse D. Jr., US
|
| (73) |
Genzyme Corporation,
500 Kendall Street, Cambridge, MA 02142,
US
The General Hospital Corporation, Massachusetts General Hospital 55 Fruit Street, Boston, MA 02114, US |
| (54) | ANTIBODIES TO TGF-BETA FOR USE IN THE TREATMENT OF INFANTS AT RISK OF DEVELOPING BRONCHOPULMONARY DYSPLASIA |
| ANTIBODIES TO TGF-BETA FOR USE IN THE TREATMENT OF INFANTS AT RISK OF DEVELOPING BRONCHOPULMONARY DYSPLASIA |